Dr. Franco Cavalli: Highlights of  ICML 2023 & the Emerging Significance of China in Lymphoma Research

Dr. Franco Cavalli: Highlights of  ICML 2023 & the Emerging Significance of China in Lymphoma Research

From June 13-17, 2023, the biennial international lymphoma academic event - the 17th International Conference on Malignant Lymphoma (ICML) was held in Lugano. As the world's largest international conference on malignant lymphoma, ICML attracts widespread attention from lymphoma experts and scholars both domestically and abroad. In our interview with the conference chair, Dr. Franco Cavalli, he highlighted the main aspects of the ICML conference, discussed the significance of the joint session between the Union of Chinese Clinical Oncology Lymphoma Alliance (UCLI) and ICML, and provided insights into the future collaboration between the International Extranodal Lymphoma Study Group (IELSG) and UCLI.
Dr. Massimo Federico: 10-Year Follow-up Results of Early FDG-PET Adaptive Treatment for Limited-Stage HL

Dr. Massimo Federico: 10-Year Follow-up Results of Early FDG-PET Adaptive Treatment for Limited-Stage HL

At the International Malignant Lymphoma Conference (ICML 2023), Dr. Massimo Federico from University of Modena and Reggio Emilia, presented a captivating report on 10-Year Follow-up Analysis of the EORTC/LYSA/FIL H10 Randomized Intergroup Trial during the "Focus on Hodgkin Lymphoma" session. Oncology Frontier specially invited Dr. Federico for an in-depth interview on this topic.